Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 21073199, 화합물 → 7-{4-[4-(1-Methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-8-yl)-piperazin-1-yl]-butoxy}1H-[1,8]naphthyridin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | HCID 21073199 | HCID 21073199 | — |
| 반응물 | 4-(7-Oxo-7,8-dihydro-1,8-naphthyridin-2-yloxy)butanal | HCID 21073380 | — |
| 생성물 | 7-{4-[4-(1-Methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-8-yl)-piperazin-1-yl]-butoxy}1H-[1,8]naphthyridin-2-one | HCID 21073495 | — |
반응 단계
In a manner similar to that of other examples above, 1-methyl-8-piperazin-1-yl-3,4-dihydro-1H-quinolin-2-one hydrochloride was coupled by reductive amination to 4-(7-oxo-7,8-dihydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde followed by typical workup and purification to give the title compound. MS: APCI: M+1: 462.2 (Exact Mass: 461.24).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07160888B2 |
| 출처 데이터셋 | uspto-grants-2007_01 |
| ORD ID | ord-9cbd6ee24a5e4d198b816ee47cf67d6e |
| 출처 메모 | uspto-grants-2007_01 |